Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CYP2C9 Polymorphism”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableStudy completedNCT00334464
What this trial is testing

A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"

Who this might be right for
Atrial FibrillationDeep Vein ThrombosisPulmonary Embolism
Intermountain Health Care, Inc. 200
Not applicableStudy completedNCT00806013
What this trial is testing

Study the Effects of CYP2C Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Glipizide

Who this might be right for
Healthy
Chinese Academy of Sciences 36
Not applicableStudy completedNCT00830570
What this trial is testing

The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings

Who this might be right for
Embolism and ThrombosisEmbolismVascular Diseases+4 more
Medco Health Solutions, Inc. 1,635
Not applicableUnknownNCT03797534
What this trial is testing

Individualized Administration of Warfarin by Polymorphisms of VKORC1 and CYP2C9 Genes

Who this might be right for
Heart Valve Prosthesis
Fujian Medical University 600
Not applicableUnknownNCT00162474
What this trial is testing

Determinants of Warfarin Metabolism

Who this might be right for
Healthy
Hadassah Medical Organization 600
Not applicableUnknownNCT00247702
What this trial is testing

The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR

Who this might be right for
Deep Venous Thromboembolism
National Taiwan University Hospital 120
Post-approval studies (Phase 4)WithdrawnNCT00377143
What this trial is testing

PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care

Who this might be right for
Blood Coagulation Disorders
University of Florida
Post-approval studies (Phase 4)UnknownNCT04449471
What this trial is testing

Naproxen Pharmacogenetic Study (Project 1, Aim 2)

Who this might be right for
Pharmacogenetics
University of Washington 30
Not applicableStudy completedNCT02428660
What this trial is testing

Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM

Who this might be right for
Cytochrome P450 CYP2D6 Enzyme DeficiencyPoor Metabolizer Due to Cytochrome P450 CYP2D6 VariantUltrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant+6 more
Genelex Corporation 341
Not applicableUnknownNCT00970892
What this trial is testing

VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management

Who this might be right for
Atrial FibrillationCardiac ThrombusDeep Vein Thrombosis+4 more
Ankara University 500
Not applicableStudy completedNCT05983042
What this trial is testing

Effect of CYP2C9*3 Polymorphism on Ibuprofen in Pakistani Population

Who this might be right for
Healthy Volunteers
Riphah International University 200
Not applicableStudy completedNCT01224457
What this trial is testing

Effect of CYP2C9/CYP2C19 Polymorphism on Pharmacokinetics of Phenobarbital in Korean Neonatal Seizure Patients.

Who this might be right for
Neonatal Seizure
Yonsei University 52
Post-approval studies (Phase 4)Looking for participantsNCT07072624
What this trial is testing

Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)

Who this might be right for
SeizuresTraumatic Brain InjuriesTraumatic Brain Injury (TBI) Patients
All India Institute of Medical Sciences, Jodhpur 1,260
Not applicableUnknownNCT06120543
What this trial is testing

CYP1A2, ABCB1, CYP2C9 and Plasma Concentration of Agomelatine in Adult Patients With Depression

Who this might be right for
Polymorphism, GeneticDepressionCYP1A2 Polymorphism+3 more
Affiliated Hospital of Nantong University 50
Not applicableStudy completedNCT02191358
What this trial is testing

YouScript IMPACT Registry

Who this might be right for
Adverse Drug EventsAdverse Drug ReactionsDrug Interaction Potentiation+10 more
Genelex Corporation 800